Evidence map›Paper›PMID 34639089›Full record

ArticleInternational journal of molecular sciences2021

Viera Horvathova Kajabova, Andrea Soltysova, Lucia Demkova, Paulina Plesnikova, Darina Lyskova, Alena Furdova, Pavel Babal, Bozena Smolkova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Viera Horvathova KajabovaCancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0002-7081-0602
Andrea SoltysovaDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovicova 6, 841 04 Bratislava, Slovakia.ORCID 0000-0002-1402-3583
Lucia DemkovaCancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia.
Paulina PlesnikovaDepartment of Ophthalmology, Faculty of Medicine, Comenius University in Bratislava, Ruzinovska 6, 821 01 Bratislava, Slovakia.
Darina LyskovaDepartment of Ophthalmology, Faculty of Medicine, Comenius University in Bratislava, Ruzinovska 6, 821 01 Bratislava, Slovakia.
Alena FurdovaDepartment of Ophthalmology, Faculty of Medicine, Comenius University in Bratislava, Ruzinovska 6, 821 01 Bratislava, Slovakia.ORCID 0000-0001-5689-892X
Pavel BabalDepartment of Pathology, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.ORCID 0000-0001-8170-1850
Bozena SmolkovaCancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0002-4906-5652
Comenius University Bratislava · SKSlovak Academy of Sciences · SKBiomedical Research Center of the Slovak Academy of Sciences · SK

Funding

Slovak Research and Development Agency APVV-17-0369VEGA 1/0395/21
6 · The paper itself

Abstract

Uveal melanoma (UM) is an ocular tumor with a dismal prognosis. Despite the availability of precise molecular and cytogenetic techniques, clinicopathologic features with limited accuracy are widely used to predict metastatic potential. In 51 UM tissues, we assessed a correlation between the expression of nine proteins evaluated by immunohistochemistry (IHC) (Melan-A, S100, HMB45, Cyclin D1, Ki-67, p53,

Indexed as

DNA MethylationGene Expression Regulation, NeoplasticAdultAgedAged, 80 and overBiomarkers, TumorCombined Modality TherapyFemaleFollow-Up StudiesHumansMaleMelanomaMiddle AgedMultiplex Polymerase Chain ReactionPrognosisProto-Oncogene Proteins c-kitBiomarkers, TumorKIT protein, humanProto-Oncogene Proteins c-kitDNA methylationKITMLPAMonosomy 3protein expressionuveal melanoma

Identifiers

PMID34639089
PMCPMC8509522
OpenAlexW3204283653

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.